Skip to main content

Advertisement

Table 5 Incidence of adverse events reported

From: Comparative study of the efficacy and tolerability of dihydroartemisinin - piperaquine - trimethoprim versus artemether - lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Cameroon, Ivory Coast and Senegal

  DPT (N = 206) n (%) AL (N = 197) n (%)
Vomiting* 21 (10.2) 6(3)
Abdominal pain 5 (2.4) 3 (1.5)
Pruritus 6 (3) 2 (1)
Asthenia 2 (1) 5 (2.5)
Nausea 4 (2) 3 (1.5)
Dizziness 1 (0.5) 4 (2)
Epigastric pain 3 (1.5) 0 (0)
Diarrhoea 2 (1) 0 (0)
Skin rash 2(1) 0 (0)
Hypoglycaemia 0 (0) 2(1)
Insomnia 0 (0) 2 (1)
Facial oedema 0 (0) 2 (1)
Drowsiness 2 (1) 0 (0)
Aphthous ulcers 0 (0) 1 (0.5)
Skin fold lesions 0 (0) 1 (0.5)
Rash 1 (0.5) 0 (0)
Productive cough 1 (0.5) 0 (0)
Total 50 31
  1. * p = 0.038, Pearson's Chi-2 test